Biosimilar

Results: 639



#Item
311Pharmacology / Pharmaceutical industry / Therapeutics / United States Public Health Service / Center for Drug Evaluation and Research / Drug development / Prescription Drug User Fee Act / California Institute for Quantitative Biosciences / Biosimilar / Food and Drug Administration / Pharmaceutical sciences / Clinical research

OCP Update May 4, 2012 PhRMA IQC

Add to Reading List

Source URL: www.fda.gov

Language: English
312Pharmacology / Clinical pharmacology / Therapeutics / United States Public Health Service / Center for Drug Evaluation and Research / Center for Devices and Radiological Health / Doctor of Pharmacy / Biosimilar / Biologic / Pharmaceutical sciences / Food and Drug Administration / Clinical research

U.S. Food and Drug Administration Office of Health and Constituent Affairs (OHCA) White Oak Campus, 10903 New Hampshire Ave., Bldg. 31 Conference Center, the Great Room (Section A), Silver Spring MD[removed]:45 - 8:15 AM

Add to Reading List

Source URL: www.fda.gov.

Language: English
313Food and Drug Administration / Pharmaceuticals policy / Biosimilar / Biotechnology / Drugs / Prescription Drug User Fee Act / FDA Special Protocol Assessment / Clinical trial / Regulatory requirement / Pharmaceutical sciences / Pharmacology / Clinical research

PDUFA REAUTHORIZATION PERFORMANCE GOALS AND PROCEDURES FISCAL YEARS 2013 THROUGH 2017

Add to Reading List

Source URL: www.fda.gov.

Language: English
314Pharmaceutical sciences / Biosimilar / Center for Biologics Evaluation and Research / Biologic / New Drug Application / Investigational New Drug / Center for Drug Evaluation and Research / Food and Drug Administration / Medicine / Health

Microsoft Word - 10519dft.doc

Add to Reading List

Source URL: www.fda.gov.

Language: English
315Clinical research / Pharmacology / Pharmaceuticals policy / Prescription Drug User Fee Act / Biosimilar / Biologic / Hospira / Center for Biologics Evaluation and Research / Pharmaceutical Research and Manufacturers of America / Food and Drug Administration / Medicine / Pharmaceutical sciences

FDA-Industry Stakeholder Meeting for a 351(k) User Fee Program: August 2, 2011

Add to Reading List

Source URL: www.fda.gov

Language: English
316Biosimilar / Biologic / Etanercept / Clinical research / Dai-ichi / Pharmacology / Daiichi Sankyo / Medicine

Microsoft Word - 20140818_エタネルセプトBS_P3開始_EN_fin.doc

Add to Reading List

Source URL: www.daiichisankyo.com

Language: English - Date: 2015-03-31 00:51:01
317Pharmaceutical sciences / Biosimilar / New Drug Application / Federal Food /  Drug /  and Cosmetic Act / Food and Drug Administration / Medicine / Pharmacology

Citizen Petitions and Petitions for Stay of Action Subject to Section 505(q) of the Federal Food, Drug, and Cosmetic Act Guidance for Industry

Add to Reading List

Source URL: www.fda.gov.

Language: English
318Research / Investigational New Drug / New Drug Application / Center for Biologics Evaluation and Research / Clinical trial / Center for Drug Evaluation and Research / Biosimilar / Federal Food /  Drug /  and Cosmetic Act / Food and Drug Administration / Medicine / Health

Microsoft Word - 10969dft.doc

Add to Reading List

Source URL: www.fda.gov.

Language: English
319Biosimilar / Biotechnology / Drugs / Food and Drug Administration / Biologic / Clinical pharmacy / Pharmacy / Pharmaceutical sciences / Pharmacology / Clinical research

Microsoft Word - FDA_AMCPComments_PharmacologyStudiestoSuppportBiosimilarity_August2014

Add to Reading List

Source URL: www.amcp.org

Language: English - Date: 2014-08-12 11:24:23
320Clinical research / Pharmaceuticals policy / Prescription Drug User Fee Act / Biosimilar / Fee / Pharmaceutical sciences / Food and Drug Administration / Pharmacology

Presentation Slide Template (DIA)

Add to Reading List

Source URL: www.fda.gov.

Language: English
UPDATE